ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China · Delayed Price · Currency is CNY 23.15
-0.18 (-0.77%)
Jul 29, 2026, 3:00 PM CST
ChengDu ShengNuo Biotec Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 207.47 | 281.05 | 218.71 | 219.13 | 372.12 | 211.56 |
Trading Asset Securities | 90.25 | 20.25 | 20.16 | 50 | - | 200 |
Cash & Short-Term Investments | 297.72 | 301.3 | 238.86 | 269.13 | 372.12 | 411.56 |
Cash Growth | 60.71% | 26.14% | -11.25% | -27.68% | -9.58% | 217.74% |
Accounts Receivable | 208.13 | 177.98 | 125.2 | 115.89 | 119.16 | 111.73 |
Other Receivables | 15.71 | 14.81 | 7.97 | 10.27 | 23.63 | 9.49 |
Receivables | 223.84 | 192.79 | 133.17 | 126.16 | 142.79 | 121.22 |
Inventory | 360.61 | 336.17 | 304.75 | 194.33 | 135.43 | 101.36 |
Prepaid Expenses | - | - | - | 0.22 | - | - |
Other Current Assets | 65.9 | 51.16 | 41.42 | 19.47 | 15.54 | 17.85 |
Total Current Assets | 948.07 | 881.43 | 718.21 | 609.3 | 665.89 | 652.01 |
Property, Plant & Equipment | 772.22 | 773.03 | 727.43 | 483.86 | 285.1 | 238.06 |
Long-Term Investments | 161.54 | 157.06 | 111.04 | 94.43 | 55.69 | 9.9 |
Other Intangible Assets | 80.37 | 80.94 | 40.2 | 35.48 | 36.3 | 36.48 |
Long-Term Deferred Tax Assets | 13.29 | 12.97 | 9.48 | 4.04 | 3.84 | 3.46 |
Long-Term Deferred Charges | 16.44 | 16.57 | 14.1 | 19.98 | 15.43 | 10.93 |
Other Long-Term Assets | 16.52 | 12.53 | 27.44 | 68.64 | 45.75 | 5.78 |
Total Assets | 2,008 | 1,935 | 1,648 | 1,316 | 1,108 | 956.62 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 81.54 | 76.23 | 108.54 | 51.05 | 28.55 | 7.83 |
Accrued Expenses | 14.46 | 49.46 | 47.24 | 48.12 | 57.01 | 49.65 |
Short-Term Debt | 179.52 | 205.54 | 200.16 | 37.03 | 50.41 | 30.05 |
Current Portion of Long-Term Debt | 80.77 | 150.93 | 99.63 | 34.05 | 2 | - |
Current Portion of Leases | - | 28.5 | 0.6 | 0.82 | 0.75 | 0.68 |
Current Income Taxes Payable | 21.68 | 17.01 | 2.61 | 8.74 | 5.07 | 4.19 |
Current Unearned Revenue | 15.69 | 50.88 | 26.89 | 9.53 | 17.99 | 14.59 |
Other Current Liabilities | 53.1 | 47.97 | 57.8 | 51.93 | 63.21 | 55.48 |
Total Current Liabilities | 446.76 | 626.52 | 543.46 | 241.28 | 225 | 162.46 |
Long-Term Debt | 316.14 | 150.16 | 182.03 | 189.19 | 48.05 | - |
Long-Term Leases | - | 54.54 | - | 0.6 | 1.42 | 2.17 |
Long-Term Unearned Revenue | 33.96 | 34.73 | 4.09 | 4.56 | 5.72 | 6.85 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 1.07 | - |
Other Long-Term Liabilities | 86.9 | 10.98 | - | - | - | - |
Total Liabilities | 883.76 | 876.93 | 729.58 | 435.63 | 281.27 | 171.48 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 157.39 | 157.39 | 112.42 | 112 | 80 | 80 |
Additional Paid-In Capital | 348.16 | 347.43 | 389.59 | 379.22 | 408.36 | 407.25 |
Retained Earnings | 619.14 | 552.78 | 416.33 | 388.71 | 338.37 | 297.89 |
Total Common Equity | 1,125 | 1,058 | 918.34 | 879.93 | 826.74 | 785.14 |
Minority Interest | - | - | -0.02 | 0.17 | - | - |
Shareholders' Equity | 1,125 | 1,058 | 918.32 | 880.1 | 826.74 | 785.14 |
Total Liabilities & Equity | 2,008 | 1,935 | 1,648 | 1,316 | 1,108 | 956.62 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 576.43 | 589.67 | 482.42 | 261.7 | 102.64 | 32.89 |
Net Cash (Debt) | -278.7 | -288.37 | -243.56 | 7.43 | 269.48 | 378.68 |
Net Cash Growth | - | - | - | -97.24% | -28.84% | 192.35% |
Net Cash Per Share | -1.26 | -1.30 | -1.11 | 0.03 | 1.24 | 1.92 |
Filing Date Shares Outstanding | 220.34 | 220.34 | 220.34 | 219.52 | 219.52 | 219.52 |
Total Common Shares Outstanding | 220.34 | 220.34 | 220.34 | 219.52 | 219.52 | 219.52 |
Working Capital | 501.31 | 254.91 | 174.75 | 368.03 | 440.89 | 489.55 |
Book Value Per Share | 5.10 | 4.80 | 4.17 | 4.01 | 3.77 | 3.58 |
Tangible Book Value | 1,044 | 976.66 | 878.15 | 844.45 | 790.44 | 748.66 |
Tangible Book Value Per Share | 4.74 | 4.43 | 3.99 | 3.85 | 3.60 | 3.41 |
Buildings | - | 306 | 235.44 | 104.44 | 101.29 | 96.46 |
Machinery | - | 578.68 | 318.26 | 254.46 | 44.74 | 198.53 |
Construction In Progress | - | 114.51 | 348.97 | 274.37 | 83.64 | 50.06 |